Ascendia Pharmaceuticals, INC.
At a glance
Employees1-19
In business sinceNot reported
HeadquartersNorth Brunswick, NJ
US patents1
SAM.gov UEIYNWYGC7GMQP4
CAGE code7F4C4
Incorporated inNJ
- formulation development
- formulations
- ICH Stability Studies
- cGMP manufacturing
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
1 US patent granted OCT 6, 2020.
Pharmaceuticals 1
- Parenteral sustained-release delivery of carvedilol disperse systemsUS 10,792,244 · granted OCT 6, 2020
Granted to Ascendia Pharmaceuticals, LLC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Ascendia Pharmaceuticals, INC. | North Brunswick | NJ | 1–19 | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.

